GoldCoin Health Foods Limited has announced the approval of its unaudited financial results for the third quarter and nine months ended December 31, 2025. The company informed BSE Limited about this corporate development through an official communication dated January 23, 2026.

Board Meeting Details

The Board of Directors convened at the company's registered office in Ahmedabad to review and approve the financial results. The meeting was held in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.

Financial Results Approval

The board considered and approved the unaudited financial results covering two specific periods. The results have been prepared along with a Limited Review Report as per regulatory requirements.

Approved Results Coverage:

• Third quarter ended December 31, 2025
• Nine months ended December 31, 2025
• Accompanied by Limited Review Report

Regulatory Compliance

The announcement was made pursuant to the second provision to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. Managing Director Devang P Shah (DIN: 00633868) signed the official communication to BSE Limited.

Company Information

GoldCoin Health Foods Limited operates from its registered office located at A-16, 1st Floor, Vardan Tower, Pragatinagar, Naranpura, Ahmedabad – 380 013. The company is incorporated under CIN: L15419GJ1989PLC012041 and trades on BSE under code 538542.

The company has fulfilled its disclosure obligations by informing the stock exchange about the board meeting outcome and the approval of quarterly financial results within the stipulated regulatory timeframe.

GoldCoin Health Foods Limited has announced that its board of directors will convene on January 23, 2026, to review and approve the company's third quarter financial results for FY26. The meeting notice was formally communicated to BSE Limited on January 9, 2026, in compliance with regulatory requirements.

Meeting Details and Regulatory Compliance

The board meeting has been scheduled under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided prior intimation to ensure transparency and keep stakeholders informed about the upcoming financial disclosure.

Agenda Items

The board meeting will focus on two primary agenda items. The main objective is to consider and approve the unaudited financial results for the third quarter and nine months ended December 31, 2025. Additionally, the board may address any other business matters that arise with the consent of the chair.

Corporate Communication

The formal notice was signed by Devang P Shah, Managing Director of GoldCoin Health Foods Limited, bearing DIN 00633868. The communication was directed to BSE Limited at Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai, ensuring proper regulatory compliance and market transparency.

The company has requested BSE Limited to inform stock exchange members and the public about the scheduled board meeting, maintaining adherence to disclosure norms and keeping stakeholders updated on corporate developments.